Regen BioPharma (Regen BioPharma) FCF Yield % : -16.68 (As of May. 21, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Regen BioPharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Regen BioPharma's Trailing 12-Month Free Cash Flow is $-0.48 Mil, and Market Cap is $2.88 Mil. Therefore, Regen BioPharma's FCF Yield % for today is -16.68%.

The historical rank and industry rank for Regen BioPharma's FCF Yield % or its related term are showing as below:

RGBP' s FCF Yield % Range Over the Past 10 Years
Min: -1897.08 Med: -14.6 Max: 3.84
Current: -16.68

During the past 11 years, the highest FCF Yield % of Regen BioPharma was 3.84%. The lowest was -1897.08%. And the median was -14.60%.

RGBP's FCF Yield % is ranked worse than
54.31% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs RGBP: -16.68

Regen BioPharma's FCF Margin % for the quarter that ended in Mar. 2024 was -354.24%.

Regen BioPharma FCF Yield % Historical Data

The historical data trend for Regen BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regen BioPharma FCF Yield % Chart

Regen BioPharma Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Yield %

Get a 7-Day Free Trial

-73.03

3.95

-0.85

-1.86

-2.75

Regen BioPharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-3.22	-5.42	-1.45	-18.19	-27.09

Competitive Comparison of Regen BioPharma's FCF Yield %

For the Biotechnology subindustry, Regen BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regen BioPharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's FCF Yield % falls into.

Regen BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Regen BioPharma's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.174	/	6.32899785
	=	-2.75%

Regen BioPharma's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.209	*	4	/	3.085965
	=	-27.09%

Regen BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Regen BioPharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Regen BioPharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regen BioPharma (Regen BioPharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regen BioPharma Inc (OTCPK:RGBP) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

RGBPP.PFD:USA

Address

4700 Spring Street, Suite 304, La Mesa, CA, USA, 91942

Website

https://www.regenbiopharmainc.com

Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.